Report Detail

Pharma & Healthcare Global (United States, European Union and China) Coartem (Artemether/Lumefantrine) Market Research Report 2019-2025

  • RnM3446790
  • |
  • 16 July, 2020
  • |
  • Global
  • |
  • 115 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Coartem (Artemether/Lumefantrine) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Coartem (Artemether/Lumefantrine) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Coartem (Artemether/Lumefantrine) market is segmented into
Artemether
Lumefantrine

Segment by Application, the Coartem (Artemether/Lumefantrine) market is segmented into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Regional and Country-level Analysis
The Coartem (Artemether/Lumefantrine) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Coartem (Artemether/Lumefantrine) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Coartem (Artemether/Lumefantrine) Market Share Analysis
Coartem (Artemether/Lumefantrine) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Coartem (Artemether/Lumefantrine) business, the date to enter into the Coartem (Artemether/Lumefantrine) market, Coartem (Artemether/Lumefantrine) product introduction, recent developments, etc.

The major vendors covered:
Novartis
Sanofi-Aventis
KPC Pharmaceuticals, Inc
Guangxi Xiancaotang Pharmaceutical Co., LTD
Guilin Pharmaceutical Co., Ltd
Kerui Nanhai Pharmaceutical
Kunming Pharmaceutical
...


1 Study Coverage

  • 1.1 Coartem (Artemether/Lumefantrine) Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Coartem (Artemether/Lumefantrine) Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Coartem (Artemether/Lumefantrine) Market Size Growth Rate by Type
    • 1.4.2 Artemether
    • 1.4.3 Lumefantrine
  • 1.5 Market by Application
    • 1.5.1 Global Coartem (Artemether/Lumefantrine) Market Size Growth Rate by Application
    • 1.5.2 Hospital Pharmacy
    • 1.5.3 Retail Pharmacy
    • 1.5.4 Online Pharmacy
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Coartem (Artemether/Lumefantrine) Market Size, Estimates and Forecasts
    • 2.1.1 Global Coartem (Artemether/Lumefantrine) Revenue 2015-2026
    • 2.1.2 Global Coartem (Artemether/Lumefantrine) Sales 2015-2026
  • 2.2 Global Coartem (Artemether/Lumefantrine), Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Coartem (Artemether/Lumefantrine) Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Coartem (Artemether/Lumefantrine) Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Coartem (Artemether/Lumefantrine) Competitor Landscape by Players

  • 3.1 Coartem (Artemether/Lumefantrine) Sales by Manufacturers
    • 3.1.1 Coartem (Artemether/Lumefantrine) Sales by Manufacturers (2015-2020)
    • 3.1.2 Coartem (Artemether/Lumefantrine) Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Coartem (Artemether/Lumefantrine) Revenue by Manufacturers
    • 3.2.1 Coartem (Artemether/Lumefantrine) Revenue by Manufacturers (2015-2020)
    • 3.2.2 Coartem (Artemether/Lumefantrine) Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Coartem (Artemether/Lumefantrine) Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Coartem (Artemether/Lumefantrine) Revenue in 2019
    • 3.2.5 Global Coartem (Artemether/Lumefantrine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Coartem (Artemether/Lumefantrine) Price by Manufacturers
  • 3.4 Coartem (Artemether/Lumefantrine) Manufacturing Base Distribution, Product Types
    • 3.4.1 Coartem (Artemether/Lumefantrine) Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Coartem (Artemether/Lumefantrine) Product Type
    • 3.4.3 Date of International Manufacturers Enter into Coartem (Artemether/Lumefantrine) Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Coartem (Artemether/Lumefantrine) Market Size by Type (2015-2020)
    • 4.1.1 Global Coartem (Artemether/Lumefantrine) Sales by Type (2015-2020)
    • 4.1.2 Global Coartem (Artemether/Lumefantrine) Revenue by Type (2015-2020)
    • 4.1.3 Coartem (Artemether/Lumefantrine) Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Coartem (Artemether/Lumefantrine) Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Coartem (Artemether/Lumefantrine) Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Coartem (Artemether/Lumefantrine) Revenue Forecast by Type (2021-2026)
    • 4.2.3 Coartem (Artemether/Lumefantrine) Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Coartem (Artemether/Lumefantrine) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Coartem (Artemether/Lumefantrine) Market Size by Application (2015-2020)
    • 5.1.1 Global Coartem (Artemether/Lumefantrine) Sales by Application (2015-2020)
    • 5.1.2 Global Coartem (Artemether/Lumefantrine) Revenue by Application (2015-2020)
    • 5.1.3 Coartem (Artemether/Lumefantrine) Price by Application (2015-2020)
  • 5.2 Coartem (Artemether/Lumefantrine) Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Coartem (Artemether/Lumefantrine) Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Coartem (Artemether/Lumefantrine) Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Coartem (Artemether/Lumefantrine) Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Coartem (Artemether/Lumefantrine) by Country
    • 6.1.1 North America Coartem (Artemether/Lumefantrine) Sales by Country
    • 6.1.2 North America Coartem (Artemether/Lumefantrine) Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Coartem (Artemether/Lumefantrine) Market Facts & Figures by Type
  • 6.3 North America Coartem (Artemether/Lumefantrine) Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Coartem (Artemether/Lumefantrine) by Country
    • 7.1.1 Europe Coartem (Artemether/Lumefantrine) Sales by Country
    • 7.1.2 Europe Coartem (Artemether/Lumefantrine) Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Coartem (Artemether/Lumefantrine) Market Facts & Figures by Type
  • 7.3 Europe Coartem (Artemether/Lumefantrine) Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Coartem (Artemether/Lumefantrine) by Region
    • 8.1.1 Asia Pacific Coartem (Artemether/Lumefantrine) Sales by Region
    • 8.1.2 Asia Pacific Coartem (Artemether/Lumefantrine) Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Coartem (Artemether/Lumefantrine) Market Facts & Figures by Type
  • 8.3 Asia Pacific Coartem (Artemether/Lumefantrine) Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Coartem (Artemether/Lumefantrine) by Country
    • 9.1.1 Latin America Coartem (Artemether/Lumefantrine) Sales by Country
    • 9.1.2 Latin America Coartem (Artemether/Lumefantrine) Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Coartem (Artemether/Lumefantrine) Market Facts & Figures by Type
  • 9.3 Central & South America Coartem (Artemether/Lumefantrine) Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Coartem (Artemether/Lumefantrine) by Country
    • 10.1.1 Middle East and Africa Coartem (Artemether/Lumefantrine) Sales by Country
    • 10.1.2 Middle East and Africa Coartem (Artemether/Lumefantrine) Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Coartem (Artemether/Lumefantrine) Market Facts & Figures by Type
  • 10.3 Middle East and Africa Coartem (Artemether/Lumefantrine) Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Novartis
    • 11.1.1 Novartis Corporation Information
    • 11.1.2 Novartis Description and Business Overview
    • 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Novartis Coartem (Artemether/Lumefantrine) Products Offered
    • 11.1.5 Novartis Related Developments
  • 11.2 Sanofi-Aventis
    • 11.2.1 Sanofi-Aventis Corporation Information
    • 11.2.2 Sanofi-Aventis Description and Business Overview
    • 11.2.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Sanofi-Aventis Coartem (Artemether/Lumefantrine) Products Offered
    • 11.2.5 Sanofi-Aventis Related Developments
  • 11.3 KPC Pharmaceuticals, Inc
    • 11.3.1 KPC Pharmaceuticals, Inc Corporation Information
    • 11.3.2 KPC Pharmaceuticals, Inc Description and Business Overview
    • 11.3.3 KPC Pharmaceuticals, Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 KPC Pharmaceuticals, Inc Coartem (Artemether/Lumefantrine) Products Offered
    • 11.3.5 KPC Pharmaceuticals, Inc Related Developments
  • 11.4 Guangxi Xiancaotang Pharmaceutical Co., LTD
    • 11.4.1 Guangxi Xiancaotang Pharmaceutical Co., LTD Corporation Information
    • 11.4.2 Guangxi Xiancaotang Pharmaceutical Co., LTD Description and Business Overview
    • 11.4.3 Guangxi Xiancaotang Pharmaceutical Co., LTD Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether/Lumefantrine) Products Offered
    • 11.4.5 Guangxi Xiancaotang Pharmaceutical Co., LTD Related Developments
  • 11.5 Guilin Pharmaceutical Co., Ltd
    • 11.5.1 Guilin Pharmaceutical Co., Ltd Corporation Information
    • 11.5.2 Guilin Pharmaceutical Co., Ltd Description and Business Overview
    • 11.5.3 Guilin Pharmaceutical Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Guilin Pharmaceutical Co., Ltd Coartem (Artemether/Lumefantrine) Products Offered
    • 11.5.5 Guilin Pharmaceutical Co., Ltd Related Developments
  • 11.6 Kerui Nanhai Pharmaceutical
    • 11.6.1 Kerui Nanhai Pharmaceutical Corporation Information
    • 11.6.2 Kerui Nanhai Pharmaceutical Description and Business Overview
    • 11.6.3 Kerui Nanhai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Kerui Nanhai Pharmaceutical Coartem (Artemether/Lumefantrine) Products Offered
    • 11.6.5 Kerui Nanhai Pharmaceutical Related Developments
  • 11.7 Kunming Pharmaceutical
    • 11.7.1 Kunming Pharmaceutical Corporation Information
    • 11.7.2 Kunming Pharmaceutical Description and Business Overview
    • 11.7.3 Kunming Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Kunming Pharmaceutical Coartem (Artemether/Lumefantrine) Products Offered
    • 11.7.5 Kunming Pharmaceutical Related Developments
  • 11.1 Novartis
    • 11.1.1 Novartis Corporation Information
    • 11.1.2 Novartis Description and Business Overview
    • 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Novartis Coartem (Artemether/Lumefantrine) Products Offered
    • 11.1.5 Novartis Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Coartem (Artemether/Lumefantrine) Market Estimates and Projections by Region
    • 12.1.1 Global Coartem (Artemether/Lumefantrine) Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Coartem (Artemether/Lumefantrine) Revenue Forecast by Regions 2021-2026
  • 12.2 North America Coartem (Artemether/Lumefantrine) Market Size Forecast (2021-2026)
    • 12.2.1 North America: Coartem (Artemether/Lumefantrine) Sales Forecast (2021-2026)
    • 12.2.2 North America: Coartem (Artemether/Lumefantrine) Revenue Forecast (2021-2026)
    • 12.2.3 North America: Coartem (Artemether/Lumefantrine) Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Coartem (Artemether/Lumefantrine) Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Coartem (Artemether/Lumefantrine) Sales Forecast (2021-2026)
    • 12.3.2 Europe: Coartem (Artemether/Lumefantrine) Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Coartem (Artemether/Lumefantrine) Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Coartem (Artemether/Lumefantrine) Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Coartem (Artemether/Lumefantrine) Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Coartem (Artemether/Lumefantrine) Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Coartem (Artemether/Lumefantrine) Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Coartem (Artemether/Lumefantrine) Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Coartem (Artemether/Lumefantrine) Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Coartem (Artemether/Lumefantrine) Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Coartem (Artemether/Lumefantrine) Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Coartem (Artemether/Lumefantrine) Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Coartem (Artemether/Lumefantrine) Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Coartem (Artemether/Lumefantrine) Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Coartem (Artemether/Lumefantrine) Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Coartem (Artemether/Lumefantrine) Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Coartem (Artemether/Lumefantrine) Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Coartem (Artemether/Lumefantrine) . Industry analysis & Market Report on Coartem (Artemether/Lumefantrine) is a syndicated market report, published as Global (United States, European Union and China) Coartem (Artemether/Lumefantrine) Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Coartem (Artemether/Lumefantrine) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,116.10
    4,674.15
    6,232.20
    3,619.20
    5,428.80
    7,238.40
    607,854.00
    911,781.00
    1,215,708.00
    325,923.00
    488,884.50
    651,846.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report